Literature DB >> 31606547

Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors.

Della Grace Thomas Parambi1, Jong Min Oh2, Seung Cheol Baek2, Jae Pil Lee2, Anna Rita Tondo3, Orazio Nicolotti4, Hoon Kim5, Bijo Mathew6.   

Abstract

The present study documents the synthesis of oxygenated chalcone (O1-O26) derivatives and their abilities to inhibit monoamine oxidases. All 26 derivatives examined showed potent inhibitory activity against MAO-B. Compound O23 showed the greatest inhibitory activity against MAO-B with an IC50 value of 0.0021 µM, followed by compounds O10 and O17 (IC50 = 0.0030 and 0.0034 µM, respectively). In addition, most of the derivatives potently inhibited MAO-A and O6 was the most potent inhibitor with an IC50 value of 0.029 µM, followed by O3, O4, O9, and O2 (IC50 = 0.035, 0.053, 0.072, and 0.082 µM, respectively). O23 had a high selectivity index (SI) value for MAO-B of 138.1, and O20 (IC50 value for MAO-B = 0.010 µM) had an extremely high SI of >4000. In dialysis experiments, inhibitions of MAO-A and MAO-B by O6 and O23, respectively, were recovered to their respective reversible reference levels, demonstrating both are reversible inhibitors. Kinetic studies revealed that O6 and O23 competitively inhibited MAO-A and MAO-B, respectively, with respective Ki values of 0.016 ± 0.0007 and 0.00050 ± 0.00003 µM. Lead compound are also non-toxic at 200 µg/mL in normal rat spleen cells. Molecular docking simulations and subsequent Molecular Mechanics/Generalized Born Surface Area calculations provided a rationale that explained experimental data.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chalcone; Kinetics; MAO inhibition; Molecular docking; Reversibility

Year:  2019        PMID: 31606547     DOI: 10.1016/j.bioorg.2019.103335

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  7 in total

1.  Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.

Authors:  Rani Sasidharan; Bo Hyun Eom; Jeong Hyun Heo; Jong Eun Park; Mohamed A Abdelgawad; Arafa Musa; Nicola Gambacorta; Orazio Nicolotti; Sreedharannair Leelabaiamma Manju; Bijo Mathew; Hoon Kim
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 2.  Chalcones as Potential Ligands for the Treatment of Parkinson's Disease.

Authors:  Ewelina Królicka; Katarzyna Kieć-Kononowicz; Dorota Łażewska
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-10

3.  Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease.

Authors:  Della Grace Thomas Parambi; Uzma Saleem; Muhammad Ajmal Shah; Fareeha Anwar; Bashir Ahmad; Amna Manzar; Aqsa Itzaz; Seetha Harilal; Md Sahab Uddin; Hoon Kim; Bijo Mathew
Journal:  Neurochem Res       Date:  2020-09-16       Impact factor: 3.996

4.  Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling.

Authors:  Begüm Nurpelin Sağlık; Betül Kaya Çavuşoğlu; Ulviye Acar Çevik; Derya Osmaniye; Serkan Levent; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  RSC Med Chem       Date:  2020-08-18

5.  Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.

Authors:  Aathira Sujathan Nair; Jong-Min Oh; Vishal Payyalot Koyiparambath; Sunil Kumar; Sachithra Thazhathuveedu Sudevan; Opeyemi Soremekun; Mahmoud E Soliman; Ahmed Khames; Mohamed A Abdelgawad; Leena K Pappachen; Bijo Mathew; Hoon Kim
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

6.  Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders.

Authors:  Payyalot Koyiparambath Vishal; Jong Min Oh; Ahmed Khames; Mohamed A Abdelgawad; Aathira Sujathan Nair; Lekshmi R Nath; Nicola Gambacorta; Fulvio Ciriaco; Orazio Nicolotti; Hoon Kim; Bijo Mathew
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

7.  Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.

Authors:  Muhammed Çeçen; Jong Min Oh; Zeynep Özdemir; Saliha Ebru Büyüktuncel; Mehtap Uysal; Mohamed A Abdelgawad; Arafa Musa; Nicola Gambacorta; Orazio Nicolotti; Bijo Mathew; Hoon Kim
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.